156 related articles for article (PubMed ID: 27836206)
1. The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes.
Li Y; Zhang HL; Kang S; Zhou RM; Wang N
Gynecol Oncol; 2017 Jan; 144(1):140-145. PubMed ID: 27836206
[TBL] [Abstract][Full Text] [Related]
2. INSR gene polymorphisms correlate with sensitivity to platinum-based chemotherapy and prognosis in patients with epithelial ovarian cancer.
Hu JL; Hu XL; Han Q; Guo AY; Wang CJ; Wen YY; Cang SD
Gene Ther; 2017 Jul; 24(7):392-398. PubMed ID: 28436941
[TBL] [Abstract][Full Text] [Related]
3. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer.
Wu JL; Zhao J; Zhang HB; Zuo WW; Li Y; Kang S
Gynecol Oncol; 2020 Oct; 159(1):270-276. PubMed ID: 32694063
[TBL] [Abstract][Full Text] [Related]
6. The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer.
Moxley KM; Benbrook DM; Queimado L; Zuna RE; Thompson D; McCumber M; Premkumar P; Thavathiru E; Hines L; Moore KN
Gynecol Oncol; 2013 Aug; 130(2):377-82. PubMed ID: 23632208
[TBL] [Abstract][Full Text] [Related]
7. nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
Li Y; Kang S; Qin JJ; Wang N; Zhou RM; Sun HY
Gynecol Oncol; 2012 Sep; 126(3):455-9. PubMed ID: 22683585
[TBL] [Abstract][Full Text] [Related]
8. Association between polymorphisms of ERCC1 and survival in epithelial ovarian cancer patients with chemotherapy.
Yan L; Shu-Ying Y; Shan K; Yip BH; Rong-Miao Z; Na W; Hai-Yan S
Pharmacogenomics; 2012 Mar; 13(4):419-27. PubMed ID: 22329723
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of receptor for advanced glycation end products and risk of epithelial ovarian cancer in Chinese patients.
Zhang S; Hou X; Zi S; Wang Y; Chen L; Kong B
Cell Physiol Biochem; 2013; 31(4-5):525-31. PubMed ID: 23571222
[TBL] [Abstract][Full Text] [Related]
10. Predicting the outcome of platinum-based chemotherapies in epithelial ovarian cancer using the 8092C/A polymorphism of ERCC1: a meta-analysis.
Li Y; Hu P; Cao Y; Wang GY; Wang N; Zhou RM
Biomarkers; 2014 Mar; 19(2):128-34. PubMed ID: 24499239
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.
Shi TY; Jiang Z; Jiang R; Yin S; Wang MY; Yu KD; Shao ZM; Sun MH; Zang R; Wei Q
Tumour Biol; 2015 Sep; 36(9):6919-27. PubMed ID: 25854172
[TBL] [Abstract][Full Text] [Related]
13. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
Jin X; Kang S; Wang N; Xing YP; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
[TBL] [Abstract][Full Text] [Related]
14. Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis.
Cai G; Ma X; Zou W; Huang Y; Zhang J; Wang D; Chen B
Gene; 2014 Aug; 546(1):117-23. PubMed ID: 23933413
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 gene and epithelial ovarian carcinoma risk.
Agachan Cakmakoglu B; Attar R; Kahraman OT; Dalan AB; Iyibozkurt AC; Karateke A; Attar E
Mol Biol Rep; 2011 Jun; 38(5):3481-6. PubMed ID: 21107726
[TBL] [Abstract][Full Text] [Related]
16. Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer.
Liu BL; Liu SJ; Baskys A; Cheng H; Han Y; Xie C; Song H; Li J; Xin XY
BMC Cancer; 2014 Nov; 14():829. PubMed ID: 25399490
[TBL] [Abstract][Full Text] [Related]
17. Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.
Dholariya S; Mir R; Zuberi M; Yadav P; Gandhi G; Khurana N; Saxena A; Ray PC
Clin Transl Oncol; 2016 Jan; 18(1):73-81. PubMed ID: 26209050
[TBL] [Abstract][Full Text] [Related]
18. [Association of functional polymorphisms on MMP-12 and MMP-13 gene promoter region with epithelial ovarian carcinoma].
Jia J; Kang S; Zhao J; Zhang X; Wang N; Zhou R; Li Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Apr; 27(2):209-13. PubMed ID: 20376807
[TBL] [Abstract][Full Text] [Related]
19. The Associations of Genetic Variants in E-cadherin Gene With Clinical Outcome of Epithelial Ovarian Cancer.
Juan W; Shan K; Na W; Rong-Miao Z; Yan L
Int J Gynecol Cancer; 2016 Nov; 26(9):1601-1607. PubMed ID: 27779545
[TBL] [Abstract][Full Text] [Related]
20. Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial Ovarian Cancer, Benign Tumors, and Healthy Ovaries.
González-Palomares B; Coronado Martín PJ; Maestro de Las Casas ML; Veganzones de Castro S; Rafael Fernández S; Vidaurreta Lázaro M; De la Orden García V; Vidart Aragon JA
Int J Gynecol Cancer; 2017 Jul; 27(6):1088-1095. PubMed ID: 28574932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]